BIOA

NASD BioAge Labs, Inc.
Oct 7, 2026 · 6:31 AM ET LAST TRADE Market Closed

$6.41 ↑ +0.12 (+1.91%) Trading Up from the previous close of $6.29

YTD change
-51.55%
vs 20-day SMA
-16.24%
vs 200-day SMA
-61.49%

Price ranges

Previous day
$6.00 $6.45
open $6.44 close $6.29
-$0.15 (-2.33%)
Today
$0.00 $0.00
$6.41
Past week
$6.00 $7.26
from $7.14 now $6.41
-$0.73 (-10.22%)
Past month
$6.00 $9.40
from $9.40 now $6.41
-$2.99 (-31.77%)
This year
$6.00 $25.96
from $13.23 now $6.41
-$6.82 (-51.55%)

Price & Performance

-11.32 (-64.28%) / 6M

$4.79$12.06$19.33$26.60Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 75.9% away from all-time highs of $26.62
  • BIOA is down 52% since the beginning of the year
  • BIOA is up 14% over the past 12 months
  • BIOA is down 32% over the past 1 month
  • 7% of all BIOA investors are betting against BIOA

BIOA reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +12.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.58
Earnings momentum +6.7% Quarterly EPS growth
Quarterly change +6.7%

Valuation

P/E ratio N/A
Enterprise value $-33873400.0
Beta 1.08

Balance sheet & scale

IncomeN/A
Revenue$10.4M
Cash$318.7M
Debt$2.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $294.2M

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,157.49 +1.26%
JNJ Johnson & Johnson $254.78 +0.73%
ABBV AbbVie, Inc. $266.69 +0.35%
MRK Merck & Co., Inc. $141.94 +1.72%
RHHVF Roche Holding Ltd $427.38 -0.12%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.